1. Home
  2. EYPT vs ECX Comparison

EYPT vs ECX Comparison

Compare EYPT & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • ECX
  • Stock Information
  • Founded
  • EYPT 1987
  • ECX 2017
  • Country
  • EYPT United States
  • ECX China
  • Employees
  • EYPT N/A
  • ECX N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • ECX EDP Services
  • Sector
  • EYPT Industrials
  • ECX Technology
  • Exchange
  • EYPT Nasdaq
  • ECX Nasdaq
  • Market Cap
  • EYPT 489.4M
  • ECX 700.0M
  • IPO Year
  • EYPT 2005
  • ECX N/A
  • Fundamental
  • Price
  • EYPT $6.15
  • ECX $2.04
  • Analyst Decision
  • EYPT Strong Buy
  • ECX Strong Buy
  • Analyst Count
  • EYPT 8
  • ECX 1
  • Target Price
  • EYPT $25.71
  • ECX $3.20
  • AVG Volume (30 Days)
  • EYPT 886.1K
  • ECX 1.5M
  • Earning Date
  • EYPT 03-06-2025
  • ECX 03-11-2025
  • Dividend Yield
  • EYPT N/A
  • ECX N/A
  • EPS Growth
  • EYPT N/A
  • ECX N/A
  • EPS
  • EYPT N/A
  • ECX N/A
  • Revenue
  • EYPT $45,713,000.00
  • ECX $778,608,168.00
  • Revenue This Year
  • EYPT N/A
  • ECX $22.31
  • Revenue Next Year
  • EYPT N/A
  • ECX $36.10
  • P/E Ratio
  • EYPT N/A
  • ECX N/A
  • Revenue Growth
  • EYPT 7.50
  • ECX 25.45
  • 52 Week Low
  • EYPT $5.90
  • ECX $0.96
  • 52 Week High
  • EYPT $29.31
  • ECX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 36.22
  • ECX 56.30
  • Support Level
  • EYPT $5.90
  • ECX $1.91
  • Resistance Level
  • EYPT $6.67
  • ECX $2.22
  • Average True Range (ATR)
  • EYPT 0.71
  • ECX 0.13
  • MACD
  • EYPT -0.04
  • ECX 0.03
  • Stochastic Oscillator
  • EYPT 8.99
  • ECX 71.65

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: